Delcath Systems (NASDAQ: DCTH) announces approval of amendments to its Clinical Trial Authorizations (CTAs) filed with the U.K.'s Medicines and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE